Vascular Disease: Milestone Achieved By Leading Medical Device Company

InspireMD Announces Groundbreaking Positive Results from C-GUARDIANS U.S. Clinical Trial.

InspireMD, a global leader in the development of innovative medical devices for the treatment of vascular diseases, recently unveiled positive 30-day follow-up results from its ongoing C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23. These promising findings mark a significant milestone not only for the company but also …